AzTrials
AzTrials

Fallopian Tube OcclusionNCT03116867

Sonosalpingography After Hysteroscopic Tubal Occlusion

An observational study of Fallopian Tube Occlusion, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Sonosalpingography is done to assess the efficacy of hysteroscopic tubal occlusion by roller ball electrode. Read more about this study

Who is it for?
Ages 20 to 40 years, women only
Conditions the study is for
Fallopian Tube Occlusion
What is being tested?
sonosalpingography
Type of treatment
Injection or infusion
How many people
56 participants
Where
1 siteEgypt
Study dates
May 2017to Apr 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • Adult

Study population: patients requiring tubal occlusion

Who may be able to join

  • Infertile patients with hydrosalpinges requiring in vitro fertilization
  • irreversible contraception

Who cannot join

  • Acute pelvic inflammatory disease

Trial locations and contacts

1 site in 1 country.

Sherif H Hussain, MD contact

0201005219239

docsherif77@yahoo.com

Egypt1 site, 1 recruiting
  • Ain Shams Maternity Hospital

    Cairo

    Sherif H Hussain, MD

    Recruiting

Other trials in Egypt

About this study

Official title: Sonosalpingography in Assessment of Efficacy of Hysteroscopic Tubal Occlusion by Roller Ball Electrode

Sonosalpingography is done to assess the efficacy of hysteroscopic tubal occlusion by roller ball electrode.

Being tested
sonosalpingography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sonosalpingographyOther

    transvaginal ultrasound with saline infusion

Study groups in NCT03116867
Study groupRoleWhat they receive
patients receiving hysteroscopic tubal occlusionThis group will have sonosalpingography done for them one month after the tubal occlusion.
Receives: Other: sonosalpingography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The presence of fluid in douglas pouch detected by transvaginal ultrasound after saline infusion through the cervix

    after saline infusion is done, presence of fluid in douglas pouch means that hysteroscopic occlusion of tubes was not successful.

    Measured: immediate

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2017
  2. Study startMay 2017 (estimated)
  3. Primary completionApr 2018 (estimated)
  4. Study completionApr 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03116867
Sponsor's protocol ID
Ainshams528
Status last verified
Apr 2017
First submitted
5 Apr 2017
Last updated
17 Apr 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Fallopian Tube Occlusion, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sherif H Hussain, MD (0201005219239, docsherif77@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The presence of fluid in douglas pouch detected by transvaginal ultrasound after saline infusion through the cervix (time frame: immediate). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in